I am not sure of the level of awareness in the US and Canada about materials called Rare Earths, their availability as a critical material for use in modern technology from electric vehicles, robotics, cellphones, autocat converters to military applications and the companies that currently produce these materials. This is an introduction to a company […]
Patalon cites an previous pattern of platinum surging when a certain point in its ratio to gold occurs. He teases some platinum mining stocks that could soar from that point, and I would like to know the Thinkolator’s take on what those are.
Is the worm finally turning?
Travis which of the the clean tech cos. do you own????????????? I think I bought the wrong one. dazed and confused-going beserk.
Any idea why it dropped so much today? Is it another buying opportunity or anything wrong with the company? Thanks.
I’m not paying $150 to figure out what they’re calling ”The Next Bitcoin.” Someone in the know please let us know…. THANX!!!
Hello. From what I read it is not about Lithium but, — BORAX —, they are talking about a company that works in the Andes and also in Death Valley. the stock is around 1.5$. I hope i am not mistaken. does anyone have some idea. Thank you for your help
Does anyone have any idea what the Weiss group is pitching with this teaser?
I’m a new subscriber……just curious as to whether anyone is familiar with the ”Square Principle” ? Sounds to be quite a remarkable tool/technique… Thanks!
Neurotrope (NTRP) will release its Bryostatin Phase 2b top line data this week (company’s guidance). The primary efficacy endpoint is based on Severe Impairment Battery Scale (SIB). Entry criteria was based on the MMSE score. Secondary efficacy endpoints were based on – Activities of Daily Living (ADL), Neuropsychiatric Inventory (NPI), and Mini-Mental State Exam (MMSE). […]
Today we’re going back to the vault to open an older Friday File article up for everyone, since the ad I was writing about in December appears to again be circulating today. This one’s about a teaser that’s being foist upon the world by Bill pantaloon at Money Map about a “gold anomaly.” I have […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. You can see all of his old articles and his most recent comments on his Stock Gumshoe page.] “Keep it quiet. (Go slow.) […]
Lots of readers have asked about the latest “almost perfect stock” pitch from Louis Navellier for his Blue Chip Growth newsletter (currently $100 a year), so that’s the Thinkolator’s project for today: What is it? Here’s the tantalizing lead-in: “Imagine… a technology company whose product you don’t install, that reduces business costs by billions a […]
can you shed some light on this.
Today we’ve got a teaser pitch for a low-priced tech stock to dig into for you — the ad is for a relatively new “back end” newsletter from Jim Pearce at Investing Daily called Breakthrough Technology Profits (not to be confused with Breakthrough Technology Alert, which is an Agora publication). Breakthrough Technology Profits will set […]
[ed. note: Michael Jorrin, who I call Doc Gumshoe, is a longtime medical writer (not a doctor) who writes for us about medicine and health a couple times a month. He has agreed to our trading and disclosure restrictions, but does not generally write directly about investment ideas. His ideas, thoughts and words are his […]